US Supreme Court stops patenting of human genes
The US Supreme Court unanimously ruled that human genes cannot be patented, drawing a red line between naturally occurring DNA sequences and artificial genes created in the lab.
Big pharma´s patent wars in India
The Indian Supreme court has rejected a key patent of Novartis for their cancer drug Glivec. The verdict adds to a series of strikes against multinational pharmaceutical companies to gain patent rights in India, potentially one of the biggest pharmaceutical markets in the world.
Mr. Rossi´s e-cat patent and black box approach
We analyzed Mr Rossi´s e-cat patent. We believe the patent lacks sufficient disclosure, is of speculative nature, the secretive black box approach is a risk for disallowance of the patent.
Rossi expects 5-year wait for US Patent on cold fusion
Italian inventor Rossi who claims having built a low energy fusion device called E-cat, expects it take upwards of five years for the US patents to be granted.
Indian government forces Bayer to accept generic Nexavar competition – FiercePharma
India has invoked its compulsory licensing rules for the first time to make and sell a version of Bayer's cancer drug Nexavar despite the fact that Nexavar is still on patent. We think this is quite a significant development. What does it mean for ROI of big pharma companies R&D ? What does it mean for IP integrity for doing business in India ?
Why ColdFusion/LENR has not been seized upon by private industry
Patent attorney view why cold fusion has not attracted more attention